Viceroy’s quick take on Grenke’s responses – and their omissions – so far. September 16, 2020 – Viceroy Research is short Grenke AG (XTRA: GLJ). You can find our original report published on Sep 15, 2020 in the following link: Grenke – For Your Fraud
Viceroy puts the spotlight on Grenke’s chicanery; swindling small businesses, laundering money for criminals, & accounting fraud. September 14, 2020 – Viceroy Research is short Grenke AG (XTRA: GLJ). Grenke’s global expansion through the purchase of dozens of undisclosed related party franchises is a fraudulent
3 July, 2020 – For posterity, please find below the infamous Zatarra Research & Investigations report on Wirecard from 2016, by Viceroy’s Fraser Perring. Four years later, this report remains entirely relevant. Weekends are bad for frauds.
May 20, 2020 – Sorrento Therapeutics’ announcement of Covid-19 “cure” follows management’s long history of unsuccessfully tailgating fads while squandering hundreds of millions in fresh investment capital. Viceroy Research are short Sorrento Therapeutics (NASDAQ:SRNE) – a biotech company with wild claims it has basically found
Not only is the factory in the wrong place, it’s not built yet November 20, 2019 – On the ground investigation of Athenex’s Chongqing factory show that the Athenex’s new API plant is not located in the Chongqing International Bio-City, and is still heavily under
Independent biotech consultants commissioned to report on Oraxol clinical data of belief Athenex will not receive New Drug Application from FDA. November 13, 2019 – Viceroy commissioned a report from a highly reputable, independent biotech consulting firm into the prospective New Drug Application (NDA) approval
Falling revenues, stalled operations, flat R&D. DOWNLOAD BRIEF November 7, 2019 – This report is a brief on Athenex’s Q3 results announcement. Viceroy will provide a further, more in depth update upon the release of Athenex’s 10-Q. Athenex revenues continue to fall Q/Q, and has
Ahead of this week’s earnings, Viceroy provide an insight of what’s to come. REPORT DOWNLOAD LINK Athenex Inc. v. Azar – Summary November 4, 2019 – This report provides a deep dive on Athenex’s significant revenue declines and capital over-commitment that investors can expect in
While his resume appears impressive, Athenex Chief Operating Officer Jeffrey Yordon has always been in the proximity of disaster, including two class action lawsuits. REPORT DOWNLOAD LINK October 29, 2019 – As we move into the sixth installment of our coverage on Athenex, Viceroy reiterate
Athenex recycle press releases to pump investors. Viceroy release details of further conflicts with Athenex CROs. REPORT DOWNLOAD LINK October 28, 2019 – This report will continue to touch on major Athenex conflict of interest issues. In another slap to the face for invetors, Athenex,